Gritstone bio, Inc.

GRTS · NASDAQ
Analyze with AI
6/30/2024
3/31/2024
12/31/2023
9/30/2023
Operating Activities
Net Income-$23-$40-$31-$38
Dep. & Amort.$2$2$2$2
Deferred Tax$0$0$1-$1
Stock-Based Comp.$3$3$3$3
Change in WC-$7-$3-$14-$1
Other Non-Cash$9$8$5$4
Operating Cash Flow-$27-$34-$34-$31
Investing Activities
PP&E Inv.-$0-$0-$0-$1
Net Acquisitions$0$0$68-$19
Inv. Purchases-$3-$0-$4-$5
Inv. Sales/Matur.$2$13$42$24
Other Inv. Act.-$1$12-$68$19
Investing Cash Flow-$1$12$38$18
Financing Activities
Debt Repay.-$0-$0$10-$0
Stock Issued$38$0$5$0
Stock Repurch.$0-$1$0-$0
Dividends Paid$0$0-$1$0
Other Fin. Act.-$2-$0$1-$0
Financing Cash Flow$36-$0$31-$0
Forex Effect$0$0$0$0
Net Chg. in Cash$9-$22$35-$13
Supplemental Information
Beg. Cash$44$65$31$49
End Cash$52$44$65$36
Free Cash Flow-$27-$34-$35-$32
Gritstone bio, Inc. (GRTS) Financial Statements & Key Stats | AlphaPilot